CIK 0001623526
- Non-accelerated filer
- Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 471144582
- Phone
- +1 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- 4 Planned sale CHIEF MEDICAL OFFICER sold 10,000 shares at $11.37 ($113,653)
- 4 Open-market sale 10% owner sold 3,600,000 shares at $11.60 ($41,760,000)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 9,426 shares at $13.23 ($124,684)
- 4 Planned sale COO & CBO sold 61,329 shares at an average $13.23 ($811,212)
- 4 Planned sale GENERAL COUNSEL & CORP SEC sold 5,126 shares at an average $13.20 ($67,668)
- 4 Open-market sale CFO sold 4,116 shares at $6.10 ($25,102)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 4,116 shares at $6.10 ($25,102)
- 4 Open-market sale COO & CBO sold 4,116 shares at $6.10 ($25,102)
- 4 Open-market sale CEO sold 11,150 shares at $6.10 ($67,999)
- 4 Open-market sale GENERAL COUNSEL & CORP SEC sold 2,349 shares at $6.10 ($14,326)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 10,000 shares at $7.75 ($77,469)
- 4 Option exercise Director acquired 31,739 shares (option exercise)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 10,000 shares at $4.80 ($47,991)
- 4 Planned sale Chief Medical Officer sold 10,000 shares at $5.74 ($57,352)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 8 of 16 · 305 filings